[61E3-61E3];[61F6-61F6];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
61E3;61F6
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC363 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d01193 to be at Release 3 genomic coordinate 1315105 on chromosome arm 3L. The Gene Disruption project determined the insertion site of the progenitor P{XP}d01193 to be at Release 3 genomic coordinate 1315208 on arm 3L. This corresponds to 61F6 on both the Release 3 and 5 genome maps. The predicted position of the progenitor PBac{WH}bab1f02681 on the Release 5 map is 61E3. Consequently, the cytological breakpoints of Df(3L)BSC363 are predicted to be 61E3;61F6.